Investor Contacts

Jennifer Ruddock
Vice President of Investor Relations and Corporate Affairs
415-482-5585

Questions for the Investor Relations Department can be submitted through the form below. Fields marked with an * are required.

Name *
Email *
Subject *
Comments *
Type in number *
	This helps Nektar Therapeutics prevent automated submissions.